How to Calculate Insulin Resistance
The hyperinsulinemic-euglycemic clamp is the gold standard reference method for quantifying insulin resistance, but for practical clinical use, HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) is the recommended first-choice method, calculated as: (fasting insulin in μU/mL × fasting glucose in mg/dL) / 405. 1, 2, 3
Gold Standard Method
The euglycemic-hyperinsulinemic clamp remains the definitive research tool for measuring insulin resistance 1. This technique involves:
- Continuous intravenous insulin infusion at a constant rate (typically 120 mU/m²·min)
- Simultaneous glucose infusion adjusted to maintain euglycemia
- The glucose disposal rate (GDR) quantifies insulin sensitivity
- Duration: approximately 3 hours
- Clinical limitation: Too complex and resource-intensive for routine practice 2
Insulin resistance cutoff from clamp studies: GDR <5.6 mg/kg fat-free mass·min or <4.9 mg/kg·min indicates insulin resistance 4
Practical Clinical Methods
HOMA-IR (Primary Recommendation)
HOMA-IR is the most practical and validated method for everyday clinical use 5, 3:
Formula: (Fasting Insulin [μU/mL] × Fasting Glucose [mg/dL]) / 405
Cutoff values:
- HOMA-IR >5.9: Indicates insulin resistance with 89% sensitivity and 67% specificity 4
- HOMA-IR 2.8-5.9 with HDL <51 mg/dL: Also suggests insulin resistance 4
- HOMA-IR >2.35: General population cutoff, though this varies by BMI category 6
- BMI-specific cutoffs: Higher values needed for obesity categories (cutoffs increase with BMI) 6
Important caveat: HOMA-IR values may be artificially lower (by approximately 2.45-fold) in patients taking SGLT2 inhibitors, despite similar actual insulin sensitivity 7
QUICKI (Alternative Index)
Formula: 1 / [log(fasting insulin μU/mL) + log(fasting glucose mg/dL)]
Cutoff: QUICKI <0.33 indicates insulin resistance 8
Matsuda Index (OGTT-Based)
Requires oral glucose tolerance test (OGTT) with insulin measurements:
- More accurate than fasting indices but more cumbersome 8, 5
- Used primarily in research settings 3
- Suitable for clinical use when OGTT is already being performed 3
Fasting Insulin Alone (Simplified Approach)
For clinical screening in children and adolescents 1:
- Normal: <15 mU/L
- Borderline high: 15-20 mU/L
- High (insulin resistant): >20 mU/L
This is less accurate than clamp methods but provides a reasonable clinical alternative 1
Cardiometabolic Risk Indices
Additional indices that incorporate lipid parameters:
- TyG-WC (Triglyceride-Glucose-Waist Circumference): Sensitivity 100%, Specificity 100% 8
- TyG-BMI: Sensitivity 100%, Specificity 100% 8
- TyG-WHtR (Waist-to-Height Ratio): Sensitivity 98%, Specificity 100% 8
- LAP (Lipid Accumulation Product): Sensitivity 84%, Specificity 100% 8
These indices may better reflect cardiometabolic risk than insulin resistance alone 9
Clinical Algorithm for Assessment
Step 1: Obtain fasting glucose and fasting insulin
- Calculate HOMA-IR using the formula above
- If HOMA-IR >5.9: Insulin resistance confirmed
- If HOMA-IR 2.8-5.9: Check HDL cholesterol; if <51 mg/dL, insulin resistance likely
Step 2: Consider BMI-specific interpretation
- Higher cutoffs appropriate for obesity categories 6
- Normal weight individuals may have insulin resistance at lower HOMA-IR values
Step 3: For ambiguous cases or research purposes
- Perform OGTT with insulin measurements to calculate Matsuda index 5, 3
- Consider referral for clamp study if diagnosis critically impacts management
Critical Pitfalls
- Lack of standardization: Different laboratories may report insulin in different units; ensure consistent units for calculations 2
- Medication effects: SGLT2 inhibitors artificially lower HOMA-IR values without changing actual insulin sensitivity 7
- Population differences: Cutoff values may vary by ethnicity, age, and BMI 6
- Not interchangeable: Different indices identify different proportions of patients as insulin resistant 5, 9
- Fasting state essential: All measurements must be obtained after appropriate fasting (typically 8-12 hours)